CJS Securities analyst Lawrence Solow upgrades Haemonetics (NYSE:HAE) from Market Perform to Outperform.
Pzena Investment Mgmt Late Wednesday Reported Q3 EPS $0.15 Down From $0.27 YoY, Sales $45.24M Down From $51.62M YoY
Pzena Investment Mgmt (NYSE:PZN) reported quarterly earnings of $0.15 per share. This is a 44.44 percent decrease over earnings of $0.27 per share from the same period last year. The company reported $45.24 million in
